|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-2-28
|
|
pubmed:abstractText |
Once weekly interferon beta-1a for multiple sclerosis (OWIMS) demonstrated modest, but significant, magnetic resonance imaging (MRI) benefit of once-weekly (qw) interferon (IFN) beta-1a at 48 weeks, but no significant effect on relapses. Objective: An OWIMS extension permitted assessment of longer-term efficacy/safety of qw IFN beta-1a in relapsing-remitting multiple sclerosis (RRMS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1352-4585
|
|
pubmed:author |
pubmed-author:AbramskyOO,
pubmed-author:BouchardJ-PJP,
pubmed-author:ComiGG,
pubmed-author:DuquettePP,
pubmed-author:FrancisG SGS,
pubmed-author:FreedmanM SMS,
pubmed-author:MetzLL,
pubmed-author:MurrayT JTJ,
pubmed-author:O'BrienFF,
pubmed-author:O'ConnorPP,
pubmed-author:Once Weekly Interferon beta-1alpha for Multiple Sclerosis Study Group,
pubmed-author:PelletierJJ,
pubmed-author:RiceG P AGP,
pubmed-author:SandersE A C MEA,
pubmed-author:University of British Columbia MS/MRI Research Group
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
41-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15732265-Adjuvants, Immunologic,
pubmed-meshheading:15732265-Adult,
pubmed-meshheading:15732265-Antibodies,
pubmed-meshheading:15732265-Female,
pubmed-meshheading:15732265-Humans,
pubmed-meshheading:15732265-Interferon-beta,
pubmed-meshheading:15732265-Magnetic Resonance Imaging,
pubmed-meshheading:15732265-Male,
pubmed-meshheading:15732265-Multiple Sclerosis, Relapsing-Remitting,
pubmed-meshheading:15732265-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS study.
|
|
pubmed:affiliation |
Ottawa Hospital - General Campus, Ottawa, Ontario, Canada. mfreedman@ottawahospital.on.ca
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
